Education
About Us
Working with TipRanks
Follow Us
Opthea Limited (AU:OPT)
ASX:OPT
OPT Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.53 - AU$1.17
Previous CloseN/A
Volume897.04K
Average Volume (3M)0.00
Market Cap
$738.77M
Enterprise ValueAU$1.13B
Total Cash (Recent Filing)$172.47M
Total Debt (Recent Filing)$141.65M
Price to Earnings (P/E)―
Beta3.25
Next Earnings
Feb 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,367,978,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.54
Enterprise Value/Revenue6.21K
Enterprise Value/Gross Profit-9.55K
Enterprise Value/Ebitda-3.97
Forecast
1Y Price Target
$0.05Price Target Upside-92.38% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering0
Opthea News
OPT FAQ
What was Opthea Limited’s price range in the past 12 months?
Opthea Limited lowest share price was AU$0.53 and its highest was AU$1.17 in the past 12 months.
What is Opthea Limited’s market cap?
Opthea Limited’s market cap is $738.77M.
When is Opthea Limited’s upcoming earnings report date?
Opthea Limited’s upcoming earnings report date is Feb 26, 2026 which is in 181 days.
How were Opthea Limited’s earnings last quarter?
Currently, no data Available
Is Opthea Limited overvalued?
According to Wall Street analysts Opthea Limited’s price is currently Overvalued.
Does Opthea Limited pay dividends?
Opthea Limited does not currently pay dividends.
What is Opthea Limited’s EPS estimate?
Opthea Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Opthea Limited have?
Opthea Limited has 1,367,978,000 shares outstanding.
What happened to Opthea Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Opthea Limited?
Currently, no hedge funds are holding shares in AU:OPT
Opthea Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$0.05 (-92.38% Downside)
$0.05 (-92.38% Downside)
Blogger Sentiment
Bullish
AU:OPT Sentiment 79%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
65.51%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-12.45%
Trailing 12-Months
Company Description
Opthea Limited
Opthea Limited (OPT) is a biotechnology company focused on developing treatments for eye diseases. The company operates primarily in the healthcare sector, with its core product being OPT-302, a novel therapy intended for the treatment of wet age-related macular degeneration (wet AMD) and other retinal vascular disorders. Opthea's mission is to enhance vision care by pioneering innovative therapies that address unmet medical needs in ophthalmology.
Technical Analysis
Immutep Ltd
―
Dimerix Limited
―
Race Oncology Ltd.
―
Clarity Pharmaceuticals Ltd.
―
Botanix Pharmaceuticals Limited
―
Ownership Overview
0.02% Insiders
2.50%
Mutual Funds
― Other Institutional Investors
96.12% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---